Inflationary Concerns Lead To Pharmaceutical Pricing Curbs

Following the government's announcement in September that it would act to reduce the price of medicines in Saudi Arabia, Minister of Health Dr Hamad Al-Manea has spelt out how this will be achieved. Drugs, generic or patented, that were first registered with the Ministry of Health five or more years ago will come under new regulations and see their prices cut by 1%. Newer drugs will have their prices

To read the full article, please sign in or take a free trial.